Koçak, Mehmet ZahidAktaş, GülaliErkuş, EdipSincer, İsaAtak, BurçinDuman, Tuba Taslamacıoğlu2021-06-232021-06-2320191806-9282https://doi.org/10.1590/1806-9282.65.1.9https://hdl.handle.net/20.500.12491/10213OBJECTIVE: Metabolic syndrome (MS) is a clinical entity that associated with increased risk of type 2 Diabetes Mellitus (DM) and cardiovascular diseases. Serum uric acid levels are correlated MS criteria. We hypothesized whether a uric acid to HDL-cholesterol ratio (UHR) could predict diabetic regulation and presence of MS in type 2 diabetic subjects. METHODS: Admissions of the subjects with type 2 DM to outpatient clinics of our institution were retrospectively analyzed. Study population grouped into well-controlled and poorly controlled diabetics according to the HbA1c level (cut off 7%) and further grouped into type 2 DM with and without MS according to the presence of MS. UHR of study groups compared. RESULTS: A hundred diabetic subjects enrolled. Mean UHR was significantly lower in well-controlled diabetics (9.7 +/- 3.7%) compared to poorly controlled subjects (14 +/- 5.4%)(p<0.001). Median UHR of diabetics with MS (13 (6-29) %) was greater than that of the diabetics without MS (9 (3-16) %) (p<0.001). UHR greater than 71% has 77% sensitivity and 60% specifity in predicting worse diabetic control (AUC: 0.752, p<0.001) and a UHR greater than 10.6% has 83% sensitivity and 71% specifity in predicting MS (AUC: 0.839, p<0.001). Sensitivity and specifity of UHR in predicting MS were better than most of the sensitivities and specifities of the five criteria of MS. CONCLUSION: We suggest utilization of UHR in diagnosis of MS as a novel criteria. Nevertheless, prospective studies with larger population may make a better scientific evidence in that issue.eninfo:eu-repo/semantics/openAccessMetabolic SyndromeDiabetes Mellitus, type 2Uric AcidHDL-cholesterolArticle10.1590/1806-9282.65.1.9651915307584142-s2.0-85061495219N/AWOS:000458029400003Q4